HLA-C and cancer: CD8+ T cells function as the key executors in the immune system’s fight against tumors, leveraging the display of peptides on the surface of cancer cells by Major Histocompatibility Complex (MHC) Class I molecules to recognize and eliminate the targeted cells (Bernal et al., 2012).